KP Tissue Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	4.43	2.43	-4.94	-10.25	1.24	-1.95	Upgrade
Loss (Gain) From Sale of Investments	0.68	0.5	0.13	4.46	5	-0.63	Upgrade
Loss (Gain) on Equity Investments	-5.17	-2.99	0.7	8.09	-6.13	1.43	Upgrade
Other Operating Activities	0.37	0.65	3.82	-2.22	-0.35	1.01	Upgrade
Change in Accounts Receivable	-	-	-	-	0.02	0.15	Upgrade
Change in Accounts Payable	-0.31	-0.6	0.29	-0.08	0.21	-	Upgrade
Investment in Securities	-	-	-	6.62	5.56	5.6	Upgrade
Other Investing Activities	6.97	6.97	6.98	-	-	-	Upgrade
Investing Cash Flow	6.97	6.97	6.98	6.62	5.56	5.6	Upgrade
Common Dividends Paid	-6.97	-6.97	-6.98	-6.62	-5.56	-5.6	Upgrade
Financing Cash Flow	-6.97	-6.97	-6.98	-6.62	-5.56	-5.6	Upgrade
Cash Income Tax Paid	-	-0.6	0.29	-0.08	2.28	1.02	Upgrade
Change in Working Capital	-0.31	-0.6	0.29	-0.08	0.23	0.15	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.